These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3539013)

  • 1. In vitro activity of DQ-2556, a new cephalosporin.
    Fujimoto T; Otani T; Nakajima R; Une T; Osada Y
    Antimicrob Agents Chemother; 1986 Oct; 30(4):611-3. PubMed ID: 3539013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of DQ-2556, a new cephalosporin.
    Ishida Y; Miyazaki S; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
    Chin NX; Zhang YX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial properties of Ro 13-99041, a long-acting new cephalosporin.
    Angehrn P; Probst PJ
    Chemotherapy; 1981; 27 Suppl 1():9-14. PubMed ID: 7249797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 May; 17(5):884-9. PubMed ID: 6772097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.
    Fujimoto T; Watanabe M; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1990 Sep; 26(3):329-41. PubMed ID: 2228824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
    Beskid G; Fallat V; Lipschitz ER; McGarry DH; Cleeland R; Chan K; Keith DD; Unowsky J
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
    Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of BMY-28142, a new cephalosporin.
    Norden CW; Neiderriter K
    Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
    Jones RN; Erwin ME
    Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime: comparative in-vitro study.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.